Certainly had the desired effect to allow those who supported the cap raise including the overhang to walk away with a substantial profit.
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-308
-
- There are more pages in this discussion • 789 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.47 |
Change
0.075(5.38%) |
Mkt cap ! $1.621B | |||
| Open | High | Low | Value | Volume |
| $1.41 | $1.50 | $1.40 | $4.347M | 3.020M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 8922 | $1.47 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.47 | 13691 | 5 |
View Market Depth
| Last trade - 13.25pm 11/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |